CUV 3.38% $13.99 clinuvel pharmaceuticals limited

who can afford afamelanotide?, page-10

  1. 492 Posts.
    lightbulb Created with Sketch. 1
    I guess the market has answered the question about the RBS analysis....On good volume too....
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.